INFI - Infinity Pharmaceuticals GAAP EPS of -$0.13 revenue of $0.69M

August, 09 2022 04:02 PM Infinity Pharmaceuticals Inc.

Infinity Pharmaceuticals press release ( NASDAQ: INFI ): Q2 GAAP EPS of -$0.13.
Revenue of $0.69M (+35.3% Y/Y).
As of June 30, 2022, we had cash, cash equivalents and available-for-sale securities of $56.6M.
"We believe that our existing cash, cash equivalents and available-for-sale securities at June 30, 2022 will be adequate to satisfy our current operating plans for at least the next twelve months from the issuance date of these financial statements."

For further details see:

Company Name:	Infinity Pharmaceuticals Inc.
Stock Symbol:	INFI
Market:	NASDAQ
Website:	infi.com